Alternative isoforms of myelin/oligodendrocyte glycoprotein with variable cytoplasmic domains are expressed in human brain

Journal of Neurochemistry

Volumn 101, Issue 2, 2007, Pages 298-312

  Allamargot, Chantal ^a   Gardinier, Minnetta V ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Alternative splicing; Demyelination; Human specific; Multiple sclerosis; Myelinogenesis; Species specific

Indexed keywords

IMMUNOGLOBULIN; ISOPROTEIN; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN;

ADOLESCENT; ADULT; ADULTHOOD; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; BRAIN SLICE; CHILD; CONTROLLED STUDY; CYTOPLASM; FETUS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; OLIGODENDROGLIA; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN VARIANT;

ADOLESCENT; ADULT; AGED; AGING; ALTERNATIVE SPLICING; ANIMALS; ANTIBODY SPECIFICITY; BRAIN; CELL LINE, TRANSFORMED; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MICE; MIDDLE AGED; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY;

PRIMATES;

EID: 34047124817     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04296.x     Document Type: Article

References (46)

1. Amiguet P., Gardinier M. V., Zanetta J.-P. and Matthieu J.-M. (1992) Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J. Neurochem. 58, 1676-1682.
2. Back S. A., Luo N. L., Borenstein N. S., Levine J. M., Volpe J. J. and Kinney H. C. (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 21, 1302-1312.
3. Ballenthin P. A. and Gardinier M. V. (1996) Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice. J. Neurosci. Res. 46, 271-281.
4. Benes F. M. (1989) Myelination of cortical-hippocampal relays during late adolescence. Schizophren. Bull. 15, 585-593.
5. Black D. L. (2000) Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 103, 367-370.
6. Brett D., Hanke J., Lehmann G., Haase S., Delbruck S., Krueger S., Reich J. and Bork P. (2000) EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett. 474, 83-86.
7. Brett D., Pospisil H., Valcarcel J., Reich J. and Bork P. (2002) Alternative splicing and genome complexity. Nat. Genet. 30, 29-30.
8. Brunner C., Lassmann H., Waehneldt T. V., Matthieu J.-M. and Linington C. (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2′, 3′-cyclic nucleotide 3′ phosphodiesterase in the CNS of adult rats. J. Neurochem. 52, 296-304.
9. Campagnoni A. T. (1988) Molecular biology of myelin proteins from the central nervous system. J. Neurochem. 51, 1-14.
10. Della Gaspera B., Pham-Dinh D., Roussel G., Nussbaum J. L. and Dautigny A. (1998) Membrane topology of the myelin/oligodendrocyte glycoprotein. Eur. J. Biochem. 258, 478-484.
11. Dermietzel R. (1974) Junctions in the central nervous system of the cat - I. Membrane fusion in central myelin. Cell Tissue Res. 148, 565-576.
12. Dyer C. A. and Matthieu J.-M. (1994) Antibodies to myelin/ oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J. Neurochem. 62, 777-787.
13. Foster L. M., Phan T., Verity A. N., Bredesen D. and Campagnoni A. T. (1993) Generation and analysis of normal and shiverer temperature-sensitive immortalized cell lines exhibiting phenotypic characteristics of oligodendrocytes at several stages of differentiation. Dev. Neurosci. 15, 100-109.
14. Gardinier M. V., Amiguet P., Linington C. and Matthieu J.-M. (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33, 177-187.
15. Givogri M. I., Bongarzone E. R. and Campagnoni A. T. (2000) New insights on the biology of myelin basic protein gene: the neuralimmune connection. J. Neurosci. Res. 59, 153-159.
16. Gow A., Southwood C. M., Li J. S., Pariali M., Riordan G. P., Brodie S. E., Danias J., Bronstein J. M., Kachar B. and Lazzarini R. A. (1999) CNS myelin and Sertoli tight junction strands are absent in Osp-Claudin-11 null mice. Cell 99, 649-659.
17. Harlow E. and Lane D. (1988) Antibodies: A Laboratory Manual. p. 418. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Jaskolski F., Normand E., Mulle C. and Coussen F. (2005) Differential trafficking of GluR7 kainate receptor subunit splice variants. J. Biol. Chem. 280, 22 968-22 976.
19. Kan Z., Rouchka E. C., Gish W. R. and States D. J. (2001) Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res. 11, 889-900.
20. Kroepfl J. F. and Gardinier M. V. (2001a) Mutually exclusive apicobasolateral sorting of two oligodendroglial membrane proteins, proteolipid protein and myelin/oligodendrocyte glycoprotein, in Madin-Darby canine kidney cells. J. Neurosci. Res. 66, 1140-1148.
21. Kroepfl J. F. and Gardinier M. V. (2001b) Identification of a basolateral membrane targeting signal within the cytoplasmic domain of myelin/ oligodendrocyte glycoprotein. J. Neurochem. 77, 1301-1309.
22. Kroepfl J. F., Viise L. R., Charron A. J., Linington C. and Gardinier M. V. (1996) Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J. Neurochem. 67, 2219-2222.
23. Lebar R., Lubetzki C., Vincent C., Lombrail P. and Boutry J. M. (1986) The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 66, 423-443.
24. Lee M. K., Tuttle J. B., Rebhun L. I., Cleveland D. W. and Frankfurter A. (1990) The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil. Cytoskeleton 17, 118-132.
25. Lees M. B. and Paxman S. A. (1972) Modification of the Lowry procedure for the analysis of proteolipid protein. Anal. Biochem. 47, 184-192.
26. Linington C., Webb M. and Woodhams P. L. (1984) A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6, 387-396.
27. Linington C., Bradl M., Lassmann H., Brunner C. and Vass K. (1988) Augmentation of demyelination in rat acute encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Amer. J. Pathol. 130, 443-454.
28. Marta C. B., Taylor C. M., Coetzee T., Kim T.,Winkler S., Bansal R. and Pfeiffer S. E. (2003) Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J. Neurosci. 23, 5461-5471.
29. Marta C. B., Montano M. B., Taylor C. M., Taylor A. L., Bansal R. and Pfeiffer S. E. (2005) Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. J Biol. Chem. 280, 8985-8993.
30. Matthieu J.-M. and Amiguet P. (1990) Myelin/oligodendrocyte glycoprotein expression during development in normal and myelindeficient mice. Dev. Neurosci. 12, 293-302.
31. Mironov A. A., Fickett J. W. and Gelfand M. S. (1999) Frequent alternative splicing of human genes. Genome Res. 9, 1288-1293.
32. Modrek B. and Lee C. J. (2003) Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat. Genet. 34, 177-180.
33. Modrek B., Resch A., Grasso C. and Lee C. J. (2001) Genome-wide analysis of alternative splicing using human expressed sequence data. Nucleic Acids Res. 29, 2850-2851.
34. Morita K., Sasaki H., Fujimoto K., Furuse M. and Tsukita S. (1999) Claudin-11/Osp-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J. Cell Biol. 145, 579-588.
35. Mugnaini E. and Schnapp B. (1974) Possible role of zonula occludens of the myelin sheath in demyelinating conditions. Nature 251, 725-727.
36. Pan Q., Bakowski M. A., Morris Q., Zhang W., Frey B. J., Hughes T. R. and Blencowe B. J. (2005) Alternative splicing of conserved exons is frequently species-specific in human and mouse. Trends Genet. 21, 73-77.
37. Pham-Dinh D., Della Gaspera B., Kerlero de Rosbo N. and Dautigny A. (1995) Structure of the human myelin/oligodendrocyte glycoprotein gene and multiple alternative spliced isoforms. Genomics 29, 345-352.
38. Pomeroy S. L. and Kim J. Y. H. (2000) Biology and pathobiology of neuronal development. Ment. Retard. Dev. Disabil. Res. Rev. 6, 41-46.
39. Rivkin M. J. (2000) Developmental neuroimaging of children using magnetic resonance techniques. Ment. Retard. Dev. Disabil. Res. Rev. 6, 68-80.
40. Scolding N. J., Frith S., Linington C., Morgan B. P., Campbell A. K. and Compston D. A. S. (1989) Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J Neuroimmunol. 22, 169-176.
41. Solly S. K., Thomas J.-L., Monge M., Demerens C., Lubetzki C., Gardinier M. V., Matthieu J.-M. and Zalc B. (1996) Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 18, 39-48.
42. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M. and Arai N. (1988) SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of the human T-cell leukemia virus 1 long terminal repeat. Mol. Cell. Biol. 8, 466-472.
43. Verity A. N., Bredesen D., Vonderscher C., Handley V. W. and Campagnoni A. T. (1993) Expression of myelin protein genes and other myelin components in a oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus. J. Neurochem. 60, 577-587.
44. Volpe J. J. (1995) Neurology of the newborn. pp. 142-146. W. B. Saunders, Philadelphia, PA.
45. Volpe J. J. (2000) Overview: normal and abnormal human brain development. Ment. Retard. Dev. Disabil. Res. Rev. 6, 1-5.
46. Yamamura T., Konola J. T., Wekerle H. and Lees M. B. (1991) Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. J. Neurochem. 57, 1671-1680.